Project Details
Description
Phase I Study of Erbitux and Velcade for Patints with Solid Tumors Expressing EGFR
| Status | Finished |
|---|---|
| Effective start/end date | 4/8/05 → 6/30/10 |
Funding
- MILLENIUM PHARM
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.